Rob Schott | SGMO Message Board Posts


Sangamo Therapeutics, Inc.

  SGMO website

SGMO   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  166924 of 168874  at  8/9/2022 5:35:14 PM  by

rynotheknife


 In response to msg 166923 by  benisgone41
view thread

Re: Rob Schott

"What effect might this have on the company?"

fortunately for all longs, SGMO has a redundant mgt structure

Sr VP Schott "is responsible for leading Sangamo's clinical development organization across all phases of drug development and regulatory approval"

whereas

Sr VP Cockroft "oversees all clinical development activities and operations"

you can't make this stuff up :-)


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 3  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
166929 Re: Rob Schott TECH32 0 8/9/2022 8:28:33 PM




Financial Market Data provided by
.
Loading...